Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS)

被引:33
作者
Ainy, E. [1 ]
Mirmiran, P. [1 ]
Asl, S. Zahedi [1 ]
Azizi, F. [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran, Iran
关键词
metabolic syndrome; menopause; women; high-density lipoprotein cholesterol;
D O I
10.1016/j.maturitas.2007.07.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This study was conducted to assess the prevalence of metabolic syndrome (MetS) in Tehranian women during menopausal transition. Design: In this cross sectional study 2182 subjects, pre-menopausal (pre-M) n=537, menopausal (M) n=311 and postmenopausal (post-M) n = 1334 were selected from 15005 participants of the TLGS and assessed for MetS risk factors. All MetS components were evaluated following age adjustment according to the ATPIII criteria. Results: The mean ages of post-M, M and pre-M women were 61.0 +/- 4.3, 53.0 +/- 4.0 and 47.0 +/- 1.9 years, respectively. The prevalence of MetS in subjects was 63% (53%, 54% and 69%) in pre-M, M and post-M women respectively. HDL-c levels was significantly higher in post-M women in comparison to pre-M women (p < 0.001). TG levels, FPG and waist circumference was significantly higher in post-M women in comparison to pre-M women (p < 0.05). The most frequent markers of MetS were low HDL-c and high diastolic blood pressure in post-M women. Conclusion: It is concluded that the frequency of MetS is significantly higher in post-M women as compared to pre-M women; low HDL-c and high diastolic blood pressure is the most frequent feature in comparison to other factors. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 35 条
  • [1] Azizi F, 2002, NUTR METAB CARDIOVAS, V12, P80
  • [2] Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
    Azizi, F
    Salehi, P
    Etemadi, A
    Zahedi-Asl, S
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) : 29 - 37
  • [3] AZIZI F, 2001, 121 NAT LIB IR, P1
  • [4] Azizi F., 2000, CVD PREVENTION INTER, V3, P242
  • [5] MENOPAUSAL EFFECTS ON RISK-FACTORS FOR ISCHEMIC HEART-DISEASE
    BENGTSSON, C
    LINDQUIST, O
    [J]. MATURITAS, 1979, 1 (03) : 165 - 170
  • [6] Bergmann S, 1997, MENOPAUSE, V4, P52
  • [7] MENOPAUSE-RELATED CHANGES IN LIPOPROTEINS AND SOME OTHER CARDIOVASCULAR RISK-FACTORS
    BONITHONKOPP, C
    SCARABIN, PY
    DARNE, B
    MALMEJAC, A
    GUIZE, L
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (01) : 42 - 48
  • [8] Casiglia E, 1996, J HYPERTENS, V14, P729
  • [9] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [10] MULTIPLE CORONARY HEART-DISEASE RISK-FACTORS ARE ASSOCIATED WITH MENOPAUSE AND INFLUENCED BY SUBSTITUTIVE HORMONAL-THERAPY IN A COHORT OF FRENCH WOMEN
    DALLONGEVILLE, J
    MARECAUX, N
    ISOREZ, D
    ZYLBERBERG, G
    FRUCHART, JC
    AMOUYEL, P
    [J]. ATHEROSCLEROSIS, 1995, 118 (01) : 123 - 133